Efficacy and Safety of Mirabegron Add-on Therapy After Failure With Solifenacin in Multiple Sclerosis Patients With Overactive Bladder: A Pilot Study.
Senem Ertugrul MutFerda SelcukSıla Usar İncirliSedef DelibasPublished in: Clinical neuropharmacology (2024)
In our study, we have found that antimuscarinic and mirabegron combination causes improved efficacy for overactive bladder in MS population.